AU4823599A - Prostate cancer-associated genes - Google Patents
Prostate cancer-associated genesInfo
- Publication number
- AU4823599A AU4823599A AU48235/99A AU4823599A AU4823599A AU 4823599 A AU4823599 A AU 4823599A AU 48235/99 A AU48235/99 A AU 48235/99A AU 4823599 A AU4823599 A AU 4823599A AU 4823599 A AU4823599 A AU 4823599A
- Authority
- AU
- Australia
- Prior art keywords
- prostate cancer
- associated genes
- genes
- prostate
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10261598A | 1998-06-22 | 1998-06-22 | |
| US09102615 | 1998-06-22 | ||
| PCT/US1999/013524 WO1999067384A2 (en) | 1998-06-22 | 1999-06-15 | Prostate cancer-associated genes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4823599A true AU4823599A (en) | 2000-01-10 |
Family
ID=22290762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU48235/99A Abandoned AU4823599A (en) | 1998-06-22 | 1999-06-15 | Prostate cancer-associated genes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1088072A2 (en) |
| JP (1) | JP2002518048A (en) |
| AU (1) | AU4823599A (en) |
| CA (1) | CA2331769A1 (en) |
| WO (1) | WO1999067384A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7202342B1 (en) | 1999-11-12 | 2007-04-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| WO2000023111A1 (en) * | 1998-10-19 | 2000-04-27 | Diadexus Llc | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| WO2000071711A2 (en) * | 1999-05-20 | 2000-11-30 | Fahri Saatcioglu | Differentially expressed genes in prostate cancer |
| CO5450246A1 (en) * | 1999-07-13 | 2004-10-29 | Smithkline Beecham Corp | VACCINE |
| WO2001034802A2 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7611892B2 (en) | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US20020009455A1 (en) * | 2000-04-27 | 2002-01-24 | Ted Lau | DNA encoding a novel PROST 03 polypeptide |
| US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| CA2429749A1 (en) * | 2000-11-28 | 2002-06-06 | Wyeth | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| EP1515982A4 (en) * | 2001-05-09 | 2005-10-26 | Corixa Corp | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US7572887B2 (en) | 2003-04-08 | 2009-08-11 | The United States Of America As Represented By The Department Of Health And Human Services | Gene expressed in prostate cancer, methods and use thereof |
| EA201300102A1 (en) | 2007-05-24 | 2014-02-28 | Глаксосмитклайн Байолоджикалс С.А. | THE LYOPHILISING ANTIGEN COMPOSITION |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786148A (en) * | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
-
1999
- 1999-06-15 AU AU48235/99A patent/AU4823599A/en not_active Abandoned
- 1999-06-15 EP EP99931806A patent/EP1088072A2/en not_active Withdrawn
- 1999-06-15 CA CA002331769A patent/CA2331769A1/en not_active Abandoned
- 1999-06-15 WO PCT/US1999/013524 patent/WO1999067384A2/en not_active Application Discontinuation
- 1999-06-15 JP JP2000556027A patent/JP2002518048A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1088072A2 (en) | 2001-04-04 |
| CA2331769A1 (en) | 1999-12-29 |
| WO1999067384A2 (en) | 1999-12-29 |
| JP2002518048A (en) | 2002-06-25 |
| WO1999067384A3 (en) | 2000-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6181300A (en) | Liver cancer-associated genes | |
| AU6005600A (en) | Data distribution | |
| AU4256299A (en) | Novel mannanases | |
| AU4823599A (en) | Prostate cancer-associated genes | |
| AU1344400A (en) | Inflammation-associated genes | |
| AU6229098A (en) | Cancer-associated genes | |
| AU2002360345A1 (en) | Prostate cancer genes | |
| HK1049682B (en) | ENDO-β-N-ACETYLGLUCOSAMINIDASE GENE | |
| AU5462699A (en) | Prostate derived ets factor | |
| GB9805877D0 (en) | Cancer | |
| AU6417799A (en) | Matrix-remodeling genes | |
| AU2238499A (en) | Androgen-metabolic gene mutations and prostate cancer risk | |
| EP1144631A3 (en) | Insulin-synthesis genes | |
| GB9828840D0 (en) | Prostate cancer associated genes and their products | |
| AU2506499A (en) | Cea/nca-based differentiation cancer therapy | |
| AU6247598A (en) | Asthma related genes | |
| EP1354948A4 (en) | Novel cancer-associated genes | |
| AU7667698A (en) | Telomere-associated chromosome fragmentation | |
| AU5316099A (en) | Prostate cancer assays and related methods | |
| AU4860299A (en) | (zap-3) tumor associated genes and their uses | |
| AU4627500A (en) | Hydroturbine | |
| GB9810997D0 (en) | Genes & enzymes | |
| AU1669600A (en) | New cancer treatments | |
| AU1045199A (en) | Cancer gene | |
| AU2002301357A1 (en) | Prostate cancer gene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |